Howe & Rusling’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-986
Closed -$25K 1011
2021
Q4
$25K Hold
986
﹤0.01% 397
2021
Q3
$27K Hold
986
﹤0.01% 373
2021
Q2
$29K Hold
986
﹤0.01% 355
2021
Q1
$26K Buy
986
+3
+0.3% +$85 ﹤0.01% 362
2020
Q4
$28K Buy
+983
New +$26.1K ﹤0.01% 341

Other funds holding BMEZ

Howe & Rusling's BMEZ Position: Q1 2022 in Review

Howe & Rusling sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2022, closing a stake of 986 shares — an estimated $25K sold.

Howe & Rusling first reported a position in BMEZ in Q4 2020 and held it in 5 quarters. The position peaked at $29K in Q2 2021. 69 funds tracked by Wall St. Rank hold BMEZ as of Q1 2022.

  • Howe & Rusling reported no remaining BlackRock Health Sciences Trust II position as of Q1 2022 after selling out during the quarter.
  • Howe & Rusling sold 986 BlackRock Health Sciences Trust II shares in Q1 2022, an estimated $25K.
  • Howe & Rusling first reported a position in BlackRock Health Sciences Trust II in Q4 2020 and held it in 5 quarters.
  • Howe & Rusling's BlackRock Health Sciences Trust II position peaked at $29K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2022.

Based on Howe & Rusling's 13F filing for Q1 2022, filed 10 May 2022.